Close Menu

NEW YORK — Evonetix said on Wednesday that it has extended its partnership with semiconductor firm Analog Devices to develop new DNA synthesis products.

Under the terms of the deal, the companies will collaborate on the development and commercial scaleup of Evonetix's proprietary microelectromechanical systems (MEMS)-based silicon chips, which are designed to synthesize DNA within thousands of independently controlled reaction sites.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.